Log In Sign up
The largest database of trusted experimental protocols

Congenic cd45.1 c57bl 6 mice

Manufactured by Charles River Laboratories
Visit Supplier

Congenic CD45.1 C57BL/6 mice are a genetic strain of laboratory mice with a specific genetic modification. The CD45.1 allele is expressed on the surface of their leukocytes, allowing for differentiation from the more common CD45.2 allele found in the C57BL/6 mouse strain.

Automatically generated - may contain errors

Lab products found in correlation

Ifnb1eyfp b6.129 ifnb1tm1lky mice25, by Jackson ImmunoResearch (2 mentions) Balb c mice, by Janvier Labs (2 mentions) C57bl 6, by Janvier Labs (2 mentions)

2 protocols using congenic cd45.1 c57bl 6 mice

1

Mice Strains for Immunological Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 and BALB/c mice were purchased from Janvier, France. Congenic CD45.1 C57BL/6 mice were purchased from Charles River, Italy. All other mouse strains were bred at the Centre d’ImmunoPhénomique (CIPHE) or the Centre d’Immunologie de Marseille-Luminy (CIML), Marseille, France, under specific pathogen free-conditions and in accordance with animal care and use regulations. Ifnb1Eyfp (B6.129-Ifnb1tm1Lky) mice25 (link) were purchased from Jackson Laboratories, USA. Tnfr1–/–Tnfr2−/− (B6.129S-Tnfrsf1atm1Imx;Tnfrsf1btm1Imx/J, TNFRDKO) were provided by J-.L.D. All animals used were age-matched females (8 to 12 weeks old unless specified otherwise). The animal care and use protocols were designed in accordance with national and international laws for laboratory animal welfare and experimentation (EEC Council Directive 2010/63/EU, September 2010). They were approved by the Marseille Ethical Committee for Animal Experimentation (registered by the Comité National de Réflexion Ethique sur l’Expérimentation Animale under no. 14; authorization #11–09/09/2011 and APAFIS#1212-2015072117438525 v5).
Abbas A., Manh T.P., Valente M., Collinet N., Attaf N., Dong C., Naciri K., Chelbi R., Brelurut G., Cervera-Marzal I., Rauwel B., Davignon J.L., Bessou G., Thomas-Chollier M., Thieffry D., Villani A.C., Milpied P., Dalod M, & Tomasello E. (2020). The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection. Nature immunology, 21(9), 983-997.
+ Open protocol
+ Expand
2

Mice Strains for Immunological Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 and BALB/c mice were purchased from Janvier, France. Congenic CD45.1 C57BL/6 mice were purchased from Charles River, Italy. All other mouse strains were bred at the Centre d’ImmunoPhénomique (CIPHE) or the Centre d’Immunologie de Marseille-Luminy (CIML), Marseille, France, under specific pathogen free-conditions and in accordance with animal care and use regulations. Ifnb1Eyfp (B6.129-Ifnb1tm1Lky) mice25 (link) were purchased from Jackson Laboratories, USA. Tnfr1–/–Tnfr2−/− (B6.129S-Tnfrsf1atm1Imx;Tnfrsf1btm1Imx/J, TNFRDKO) were provided by J-.L.D. All animals used were age-matched females (8 to 12 weeks old unless specified otherwise). The animal care and use protocols were designed in accordance with national and international laws for laboratory animal welfare and experimentation (EEC Council Directive 2010/63/EU, September 2010). They were approved by the Marseille Ethical Committee for Animal Experimentation (registered by the Comité National de Réflexion Ethique sur l’Expérimentation Animale under no. 14; authorization #11–09/09/2011 and APAFIS#1212-2015072117438525 v5).
Abbas A., Manh T.P., Valente M., Collinet N., Attaf N., Dong C., Naciri K., Chelbi R., Brelurut G., Cervera-Marzal I., Rauwel B., Davignon J.L., Bessou G., Thomas-Chollier M., Thieffry D., Villani A.C., Milpied P., Dalod M, & Tomasello E. (2020). The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection. Nature immunology, 21(9), 983-997.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!